
### [MONDO:0002120](http://purl.obolibrary.org/obo/MONDO_0002120)
**Label:** neuroendocrine carcinoma

**Subclasses:** [MONDO:0015277](http://purl.obolibrary.org/obo/MONDO_0015277) (medullary thyroid gland carcinoma), [MONDO:0003708](http://purl.obolibrary.org/obo/MONDO_0003708) (extrahepatic bile duct small cell adenocarcinoma), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0004319](http://purl.obolibrary.org/obo/MONDO_0004319) (hypercalcemic type ovarian small cell carcinoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0004318](http://purl.obolibrary.org/obo/MONDO_0004318) (pulmonary type ovarian small cell carcinoma), [MONDO:0006219](http://purl.obolibrary.org/obo/MONDO_0006219) (gallbladder small cell neuroendocrine carcinoma), [MONDO:0004117](http://purl.obolibrary.org/obo/MONDO_0004117) (ampulla of vater small cell carcinoma), [MONDO:0003920](http://purl.obolibrary.org/obo/MONDO_0003920) (gastric small cell carcinoma), [MONDO:0004115](http://purl.obolibrary.org/obo/MONDO_0004115) (gallbladder small cell carcinoma), [MONDO:0004116](http://purl.obolibrary.org/obo/MONDO_0004116) (esophagus small cell carcinoma), [MONDO:0006138](http://purl.obolibrary.org/obo/MONDO_0006138) (cervical large cell neuroendocrine carcinoma), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0004114](http://purl.obolibrary.org/obo/MONDO_0004114) (urinary bladder small cell neuroendocrine carcinoma), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0006197](http://purl.obolibrary.org/obo/MONDO_0006197) (endometrial small cell carcinoma), [MONDO:0006390](http://purl.obolibrary.org/obo/MONDO_0006390) (prostate small cell carcinoma), [MONDO:0018017](http://purl.obolibrary.org/obo/MONDO_0018017) (Goblet cell carcinoma), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0003978](http://purl.obolibrary.org/obo/MONDO_0003978) (colon small cell carcinoma), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0006405](http://purl.obolibrary.org/obo/MONDO_0006405) (salivary gland small cell carcinoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0006229](http://purl.obolibrary.org/obo/MONDO_0006229) (gastric small cell neuroendocrine carcinoma), [MONDO:0000402](http://purl.obolibrary.org/obo/MONDO_0000402) (small cell carcinoma), [MONDO:0006348](http://purl.obolibrary.org/obo/MONDO_0006348) (pancreatic small cell neuroendocrine carcinoma), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0003795](http://purl.obolibrary.org/obo/MONDO_0003795) (ovarian small cell carcinoma), [MONDO:0005057](http://purl.obolibrary.org/obo/MONDO_0005057) (large cell neuroendocrine carcinoma), [MONDO:0004122](http://purl.obolibrary.org/obo/MONDO_0004122) (thymus small cell carcinoma), [MONDO:0004120](http://purl.obolibrary.org/obo/MONDO_0004120) (Bartholin's gland small cell carcinoma), [MONDO:0006288](http://purl.obolibrary.org/obo/MONDO_0006288) (malignant adrenal gland pheochromocytoma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0006265](http://purl.obolibrary.org/obo/MONDO_0006265) (laryngeal small cell carcinoma), [MONDO:0006142](http://purl.obolibrary.org/obo/MONDO_0006142) (cervical small cell carcinoma), [MONDO:0006482](http://purl.obolibrary.org/obo/MONDO_0006482) (ureter small cell carcinoma), 

**Mapped go classes:** [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), 

**Class expressions from DL-Learner:**

- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 66.67%
- [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance) 66.67%
- [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development) 66.67%
- Thing 51.11%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 34.49%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 32.48%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 31.10%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 31.10%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 20.82%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 19.99%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 19.47%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 19.33%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 19.26%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 18.96%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 18.65%


